Literature DB >> 29651771

Remote brain microhaemorrhages may predict haematoma in glioma patients treated with radiation therapy.

Augustin Lecler1, Frédérique Charbonneau2, Dimitri Psimaras3, Marie-Astrid Metten4, Antoine Gueguen5, Khe Hoang Xuan6, Loic Feuvret7, Julien Savatovsky2,8.   

Abstract

OBJECTIVES: To evaluate the prevalence of cerebral remote microhaemorrhages (RMH) and remote haematomas (RH) using magnetic resonance susceptibility-weighted imaging (SWI) among patients treated for gliomas during follow-up.
METHODS: We conducted a retrospective single centre longitudinal study on 58 consecutive patients treated for gliomas from January 2009 through December 2010. Our institutional review board approved this study. We evaluated the presence and number of RMH and RH found outside the brain tumour on follow-up MR imaging. We performed univariate and bivariate analyses to identify predictors for RMH and RH and Kaplan-Meier survival analysis techniques.
RESULTS: Twenty-five (43%) and four patients (7%) developed at least one RMH or RH, respectively, during follow-up. The risk was significantly higher for patients who received radiation therapy (49% and 8% versus 0%) (p = 0.02). The risk of developing RH was significantly higher in patients with at least one RMH and a high burden of RMH. The mean age of those presenting with at least one RMH or RH was significantly lower.
CONCLUSIONS: RMH were common in adult survivors of gliomas who received radiation therapy and may predict the onset of RH during follow-up, mainly in younger patients. KEY POINTS: • Brain RMH and RH are significantly more likely to occur after RT. • RMH occur in almost half of the patients treated with RT. • RMH and RH are significantly more frequent in younger patients. • RH occur only in patients with RMH.

Entities:  

Keywords:  Diagnostic imaging; Intracranial haemorrhages; Magnetic resonance imaging; Radiation effects; Radiotherapy

Mesh:

Year:  2018        PMID: 29651771     DOI: 10.1007/s00330-018-5356-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

1.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-06       Impact factor: 2.571

2.  Neuro-oncology: anaplastic oligodendrogliomas-value of early chemotherapy.

Authors:  François Ducray; Ahmed Idbaih
Journal:  Nat Rev Neurol       Date:  2012-12-11       Impact factor: 42.937

Review 3.  Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis.

Authors:  Sanjaykumar Hapani; Amna Sher; David Chu; Shenhong Wu
Journal:  Oncology       Date:  2010-11-03       Impact factor: 2.935

4.  Late changes in the architecture of blood vessels of the rat brain after irradiation.

Authors:  H S Reinhold; J W Hopewell
Journal:  Br J Radiol       Date:  1980-07       Impact factor: 3.039

5.  Characterization of radiation-induced cavernous malformations and comparison with a nonradiation cavernous malformation cohort.

Authors:  Jeremy K Cutsforth-Gregory; Giuseppe Lanzino; Michael J Link; Robert D Brown; Kelly D Flemming
Journal:  J Neurosurg       Date:  2015-02-20       Impact factor: 5.115

6.  MR detection of microhemorrhages in neurologically healthy adults.

Authors:  Y Tsushima; Y Tanizaki; J Aoki; K Endo
Journal:  Neuroradiology       Date:  2002-01       Impact factor: 2.804

Review 7.  Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction.

Authors:  DeeDee Smart
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

8.  Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T.

Authors:  Wei Bian; Christopher P Hess; Susan M Chang; Sarah J Nelson; Janine M Lupo
Journal:  Neuroradiology       Date:  2013-11-27       Impact factor: 2.804

9.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Authors:  Gregory Cairncross; Meihua Wang; Edward Shaw; Robert Jenkins; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Walter Curran; Minesh Mehta
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

10.  Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.

Authors:  Nathan S Floyd; Shiao Y Woo; Bin S Teh; Charlotte Prado; Wei-Yuan Mai; Todd Trask; Philip L Gildenberg; Paul Holoye; Mark E Augspurger; L Steven Carpenter; Hsin H Lu; J Kam Chiu; Walter H Grant; E Brian Butler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.